Search clinical trials for: Latanoprost

Total 251 results

Aurolab

Unknown

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

Glaucoma

India
Aurolab

Unknown

Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost

Ocular Hypertension | Glaucoma, Open-Angle

India
Alcon Research

Completed

Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN

Ocular Hypertension | Open-angle Glaucoma
Alcon Research

Completed

Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers

Glaucoma

United States
Alcon Research

Completed

A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

Ocular Hypertension | Open-angle Glaucoma
Alcon Research

Completed

Effects of Travatan Z and Xalatan on Ocular Surface Health

Ocular Hypertension | Glaucoma
University of Catanzaro

Unknown

Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma (LATANOPROST)

Intraocular Pressure (IOP) | Tear Break-Up Time

Italy
Meir Medical Center

Withdrawn

The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) (Xal-Cos)

Ocular Hypertension | Open-Angle Glaucoma

Israel
Alcon Research

Completed

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

United States
Alcon Research

Completed

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients

Ocular Hypertension | Open-angle Glaucoma
Alcon Research

Completed

A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-angle

Belgium
Alcon Research

Completed

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
Lithuanian University of Health Sciences
Merck Sharp & Dohme LLC; Indiana University School of Medicine

Completed

Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients

Open Angle Glaucoma

Lithuania
Allergan

Completed

Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

Ocular Hypertension | Open-Angle Glaucoma

United States
Santen Inc.

Completed

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Santen Inc.

Completed

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Allergan

Completed

Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

Ocular Hypertension | Glaucoma

United States
Taiwan Otsuka Pharm. Co., Ltd

Completed

A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients

Glaucoma

Taiwan
Nanduri, Padma, M.D., FACS

Unknown

Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy

Glaucoma

United States
Ophthalmic Consultants of Long Island
Pfizer

Completed

Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®

Dry Eye Disease

United States
University of California, San Francisco

Completed

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

Alopecia Areata

United States
Centre de recherche du Centre hospitalier universitaire...

Unknown

Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma

Ocular Hypertension | Primary Glaucoma

Canada
Pfizer

Completed

A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma | Open Angle Glaucoma

United States
University of Aarhus

Completed

Pharmacological Intervention in Diabetic Retinopathy (XAVOT)

Diabetic Retinopathy

Denmark
Singapore National Eye Centre

Completed

Results of Mass Switch From Latanoprost to Travoprost

Glaucoma

Singapore
Peking University First Hospital

Unknown

Efficacy Comparison of Xalatan and Azopt on POAG and OH

Ocular Hypertension
Santen Oy

Completed

Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops

Ocular Hypertension | Open-Angle Glaucoma

Finland
The New York Eye & Ear Infirmary
Pfizer

Unknown

The International Collaborative Exfoliation Syndrome Treatment Study

Ocular Hypertension | Glaucoma | Exfoliation Syndrome

United States
United States Air Force
Alcon Research

Completed

Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative

Ocular Hypertension | Open-Angle Glaucoma | Ocular Dryness | Ocular Irritation

United States
Bp Consulting, Inc

Completed

Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)

Ocular Hypertension | Open-Angle Glaucoma

United States
University of Turin, Italy

Unknown

Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure

Glaucoma

Italy
Pharmaceutical Research Network

Completed

Cosopt Versus Xalacom

Ocular Hypertension | Open-Angle Glaucoma

Canada, Slovenia
Augusta University
Pfizer

Unknown

Effects of Xal-Ease on Patient Compliance With Xalatan (Xal-Ease)

Glaucoma

United States
Alcon Research

Completed

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Ocular Hypertension | Glaucoma, Angle-Closure

United States, Australia
Alcon Research

Completed

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Alcon Research

Completed

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Alcon Research

Completed

Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Pfizer

Completed

Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.

Ocular Hypertension | Glaucoma, Open-Angle

Sweden, Finland
University Hospital, Basel, Switzerland

Completed

Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients

Open-Angle Glaucoma

Switzerland
Allergan

Completed

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

Ocular Hypertension | Glaucoma

United States
Singapore National Eye Centre
Allergan

Unknown

Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study

Glaucoma, Angle-Closure

Singapore
Pharmaceutical Research Network

Completed

Latanoprost Versus Fotil

Ocular Hypertension | Open-Angle Glaucoma

Poland
Innovative Medical

Completed

Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Glaucoma

United States
Innovative Medical

Completed

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

Glaucoma

United States
Advanced Glaucoma Specialists
Merck Sharp & Dohme LLC

Unknown

Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.

Open Angle Glaucoma

United States
Genovate Biotechnology Co., Ltd.,
Allergan Medical

Unknown

Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy

Glaucoma

Taiwan
Pharmaceutical Research Network

Completed

Cosopt Versus Xalatan

Ocular Hypertension | Open-Angle Glaucoma

United States

3

Subscribe